Search the Newsreel

Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $277.92, Implies 7% Upside

Analysts have raised the 12-month average price target for Charles River Laboratories International, Inc. (CRL) stock from $274.85 to $277.92, indicating a 7% potential upside from its August 5th closing price. The consensus rating among 19 analysts remains "Buy," with 14 recommendations for Buy, …

Charles River Labs (CRL) CEVP sells 5,046 shares under 10b5-1 plan

Shannon M. Parisotto, CEVP of Discovery & Safety Assessment at Charles River Laboratories International, Inc. (CRL), sold 5,046 shares of common stock at $263.00 per share on August 5, 2026. This transaction was conducted under a Rule 10b5-1 Trading Plan established on March 4, …

Harley-Davidson (HOG) Reports Weaker Earnings, Is The Stock Fully Priced?

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 6, 2026)

This article details an SEC Form 144 filing by CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on August 6, 2026. The filing indicates a proposed sale of 4,179 shares of common stock acquired through a stock option exercise, with an aggregate market value of $1,086,540, …

Charles River Laboratories International Q2 Earnings Call Highlights

Charles River Laboratories International (CRL) exceeded Q2 expectations, driven by improved demand in its Discovery and Safety Assessment (DSA) business and strong manufacturing performance. The company raised its full-year guidance for revenue, earnings, and free cash flow, anticipating a gradual recovery in biopharmaceutical demand. …

Albemarle Corp (ALB) (Q2 2026) Earnings Call Highlights: Strong Demand and Record EBITDA Amid ...

This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Albemarle Corp (NYSE:ALB) delivered a strong Q2 2026 with net sales up 31% year-over-year and …

Albemarle Profit Jumps 3,300% on Lithium Demand, Shares Rally

Albemarle Corp. saw its shares rally after reporting a 3,300% surge in quarterly profit, driven by robust lithium demand, especially from the electric vehicle and energy storage markets. Earnings of $3.75 per share and revenue of $1.7 billion significantly beat Wall Street estimates, propelled …

CHARLES SCHWAB CORP CHARLES SCH (0L3I.L) Q1 FY2026 earnings call transcript

Charles Schwab reported record Q1 2026 results, with revenue up 16% year-over-year to $6.5 billion and adjusted EPS reaching $1.43, a 38% increase. The company attributed this outperformance to strong client engagement, robust asset gathering, and expanding lending. Management indicated that EPS is tracking …

FMR LLC reports 8.8% ownership of Charles River (CRL) common stock

FMR LLC has disclosed an 8.8% beneficial ownership stake in Charles River Laboratories International, Inc. (CRL) common stock as of June 30, 2026. This translates to 4,239,751.47 shares, with FMR LLC exercising sole voting power over 4,190,715.80 shares and sole dispositive power over all …

Albemarle Q2 2026 slides: lithium pricing surge drives 155% EBITDA jump

Albemarle Corporation reported a substantial turnaround in Q2 2026, with adjusted EPS of $3.75 and revenue of $1.74 billion, significantly exceeding expectations. The company's adjusted EBITDA surged by 155% year-over-year to $858 million, driven by a global lithium pricing surge and strong demand in …

Informe de resultados: Albemarle supera estimaciones del Q2 2026 y sube antes de la apertura

Earnings call transcript: Albemarle tops Q2 2026 estimates, shares rise premarket

Albemarle Corp. reported stronger-than-expected Q2 2026 results, with adjusted earnings of $3.75 a share and revenue of $1.74 billion, surpassing analyst estimates. This performance was driven by higher lithium pricing and improved specialty mix, leading to a 4.3% rise in premarket trading. The company …

Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More

This article details Thursday's top Wall Street analyst research calls, including upgrades, downgrades, and new initiations for various companies like Charles River Laboratories, Global Payments, AppLovin, and HubSpot. It also provides a snapshot of the market on Wednesday, noting mixed futures, a strong Dow …

Burley Minerals boosts director stake through placement and option grant

Is Schwab Fundamental U.S. Small Company ETF (FNDA) a Strong ETF Right Now?

The Schwab Fundamental U.S. Small Company ETF (FNDA) is highlighted as a strong smart beta ETF for investors seeking exposure to the Style Box - Small Cap Value segment. The article details FNDA's fund sponsor, index, expense ratio, top holdings, and performance, noting its …

Should Schwab U.S. Large-Cap Value ETF (SCHV) Be on Your Investing Radar?

The article analyzes the Schwab U.S. Large-Cap Value ETF (SCHV), highlighting its low expense ratio, significant assets under management, and strong performance. It targets investors seeking exposure to large-cap value stocks and notes its diversification benefits and "Strong Buy" Zacks ETF Rank. The piece …

Sei Investments Co. Purchases 114,441 Shares of Harley-Davidson, Inc. $HOG

Sei Investments Co. increased its stake in Harley-Davidson, Inc. (NYSE:HOG) by 100.8% in the first quarter, purchasing an additional 114,441 shares, bringing its total holdings to 228,009 shares valued at $4.6 million. Other institutional investors also adjusted their positions, and insider activity included a …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 2026: Revenue $1B, EPS ($0.03) — 10-Q Summary

Charles River Laboratories International, Inc. reported Q3 2026 results, with revenue of $1 billion and a diluted EPS loss of ($0.03), reflecting a 2.7% year-over-year decline in revenue and a significant drop in net income. The company is implementing cost-saving measures and restructuring actions …

Albemarle Aktie: Prognose deutlich angehoben

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : BAIRD RAISES TARGET PRICE TO $291 FROM $255

Baird has increased its target price for Charles River Laboratories International, Inc. (CRL.N) from $255 to $291. This update reflects a positive outlook from the analytical firm regarding the company's financial prospects. The news was reported by Reuters.

Charles River Laboratories International, Inc. reports results for the quarter ended June 30 - Earnings Summary

Charles River Laboratories International, Inc. has released its earnings summary for the quarter that concluded on June 30. The article, sourced from Reuters, provides a brief announcement of these results. Readers can access the full report and more news on TradingView.

ETFs Investing in Charles Schwab Corp Depositary Shs Repr 1/40th 5.95 % Non-Cum Pfd Shs Series D Stocks

This article lists various ETFs that hold Charles Schwab Corp Depositary Shares, specifically the 5.95% Non-Cumulative Perpetual Preferred Stock, Series D (SCHW/PD). It provides a detailed table including each ETF's market value, weight of SCHW/PD, issuer, management style, expense ratio, AUM, price, change, relative …

Albemarle: Aktie erholt sich nach starkem Quartal – Specialties-Prognose rauf

Albemarle Corp Q2 2026: Revenue $1.743B, EPS $3.52— 10-Q Summary

Albemarle Corp reported strong financial results for Q2 2026, with revenue increasing to $1.743B from $1.33B in the prior year, marking a 31% year-over-year change. The company achieved a net income of $438.3M, a significant improvement from a loss in Q2 2025, and diluted …

Albemarle (ALB) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, Albemarle (ALB) reported revenue of $1.74 billion, up 31.1% over the same period last year. EPS came in at $3.75, compared to $0.11 in the year-ago quarter. The reported revenue represents a surprise of +9.94% over the Zacks …

Albemarle Surges Past Expectations on Stronger Lithium Market

Albemarle exceeded Wall Street expectations for the second quarter as stronger lithium prices and resilient demand from the energy storage sector continued to lift the world's largest lithium producer. The company reported adjusted earnings of $3.75 per share on $1.7 billion in revenue, comfortably …

Harley-Davidson (NYSE:HOG) CFO Jonathan Root Sells 1,554 Shares of Stock

Harley-Davidson CFO Jonathan Root sold 1,554 shares of company stock for approximately $38,664 under a pre-arranged trading plan, reducing his ownership by 5.29%. This transaction occurred as Harley-Davidson's shares fell 1.1% to $26.21, despite the company exceeding Q2 earnings and revenue estimates. The company …

Albemarle Earnings Jump 3,300%. Commodity Prices Helped.

Wall Street was looking for earnings per share of $3.20 from sales of $1.6 billion, up from a comparable EPS of 11 cents and sales of $1.3 billion in the second quarter of 2025. Things are a lot better year over year because commodity …

ALBEMARLE ($ALB) Releases Q2 2026 Earnings, Stock Rises

Harley-Davidson Director Nova Buys 40,000 Shares for $983,000. What Does This Say About HOG's Prospects in 2026?

Daniel J. Nova, Director of Harley-Davidson, Inc. (NYSE:HOG), purchased 40,000 shares of common stock on July 31, 2026, according to a recent SEC Form 4 filing. Transaction summary Metric Value Transaction value $982,800 Shares purchased 40,000 Post-transaction shares (directly held) 47,605 Post-transaction value ~$1.17 …

Harley-Davidson (NYSE: HOG) CFO trades 1,554 shares under 10b5-1 plan

Harley-Davidson's CFO and CCO, Jonathan R. Root, sold 1,554 shares of Common Stock on August 3, 2026, at a weighted average price of $24.8802 per share. This sale was conducted under a Rule 10b5-1(c) trading plan adopted on February 17, 2026. Following the transaction, …

Albemarle posts Q2 2026 revenue $1.74B, adjusted EBITDA $858M, net income $480M

Albemarle reported strong second-quarter 2026 results, with net sales reaching $1.74 billion and adjusted EBITDA of $858.1 million. The company achieved a net income of $480.0 million, driven by robust pricing in its Energy Storage segment and volume and pricing gains in Specialties. Albemarle …

Albemarle Corporation (NYSE: ALB) lifts EBITDA 155% on Q2 2026 lithium gains

Albemarle Corporation reported strong second-quarter 2026 results, with net sales of $1.74 billion, up 31%, and adjusted EBITDA increasing 155% to $858 million, primarily driven by higher lithium pricing and growth in its Specialties segment. The Energy Storage segment saw net sales jump 78% …

Charles River Laboratories International (NYSE:CRL) Posts Earnings Results, Beats Expectations By $0.28 EPS

Albemarle Reports Second Quarter 2026 Results

Albemarle Corporation announced strong second-quarter 2026 results, with net sales up 31% to $1.7 billion and adjusted EBITDA increasing 155% to $858 million, driven by higher pricing in Energy Storage and growth in Specialties. The company also improved its full-year 2026 outlook for Specialties …

CRL (CRL) insider files Form 144 for potential 5,046-share sale

An insider at Charles River Laboratories International, Inc. (CRL) has filed a Form 144, indicating a potential sale of up to 5,046 common shares on the NYSE, with an aggregate market value of $1,327,098.00. The shares, which represent a small portion of the 47,738,872 …